Augmentin tablets Augmentin tablets Augmentin tablets Augmentin tablets

Creative Commons LicenseThis image is released under a CC BY-NC-SA 4.0 Licence

License this image for commercial use at Science and Society Picture Library

License

Creative Commons LicenseThis image is released under a CC BY-NC-SA 4.0 Licence

License this image for commercial use at Science and Society Picture Library

License

Creative Commons LicenseThis image is released under a CC BY-NC-SA 4.0 Licence

License this image for commercial use at Science and Society Picture Library

License

Creative Commons LicenseThis image is released under a CC BY-NC-SA 4.0 Licence

License this image for commercial use at Science and Society Picture Library

License

Science Museum Group
© The Board of Trustees of the Science Museum

Science Museum Group
© The Board of Trustees of the Science Museum

Science Museum Group
© The Board of Trustees of the Science Museum

Science Museum Group
© The Board of Trustees of the Science Museum

9 dispersible tablets of Augmentin in sealed foil packet made by Beecham Research Laboratories, Brentford, England, 1981-1990

Martin Cole was a microbiologist, whose career at Beecham Research Laboratories focused on the hope of developing and using semi-synthetic penicillins, including cloxacillin and amoxicillin. He led the team which first discovered and named olivanic acids and clavulanic acid and then combined the latter with amoxicillin, to produce co-amoxiclav, brand name Augmentin.

In 1957, the team at Beecham Research Laboratories discovered that penicillin grown from mould has 6-aminopenicillanic acid. By tweaking its chemical structure, scientists created medicines to treat a wider range of bacterial infections, with fewer side effects. These are known as semi-synthetic penicillins.

Details

Category:
Biotechnology
Object Number:
2025-2162
Materials:
foil and materia medica
Measurements:
overall: 5 mm x 110 mm x 110 mm,
type:
tablet